Jesper Kjaergaard: Clinical Trials

3 trials sponsored by Jesper Kjaergaard, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 31Recruiting 1

Follow Jesper Kjaergaard: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
Ultrasound assisted Thrombolysis, Percutaneous Embolectomy, Heparin - Pulmonary Embolism
Phase 3RecruitingJesper Kjaergaard2102026-06-172026-07-02
Blood Pressure and OXygenation Targets After OHCA
Low normal MAP, High normal MAP, Low normal PaO2. - Out-of-Hospital Cardiac Arrest, Blood Pressure
Not applicableCompletedJesper Kjaergaard8022017-03-102022-06-30
GLP-1 Analogs for Neuroprotection After Cardiac Arrest
Byetta (Lilly, Exenatide), 20% Human Albumin - Cardiac Arrest, Coma
Not applicableCompletedJesper Kjaergaard1202014-06-012017-09-28

Conditions studied

Coma (1)  ·  Heart Arrest (1)  ·  Out-of-Hospital Cardiac Arrest (1)  ·  Pulmonary Embolism (1)

Interventions

Exenatide (1)  ·  Heparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Serum Albumin, Human (1)

Countries

Denmark (3)

Results publications

PMID 27363489, PMID 27838646, PMID 29189347, PMID 34950913, PMID 35209951, PMID 35546563, PMID 36027564, PMID 36027567, PMID 36342119, PMID 37779885, PMID 37791480, PMID 37891623, PMID 38216985, PMID 38762578, PMID 38847097, PMID 39162825, PMID 39658315, PMID 39704227, PMID 40770665, PMID 42399677